Catheter Precision Inc
For the period ended Mar 31, 2024. Filed May 6, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2024 · Filed May 6, 2024
VTAK$0.15-0.7%Stored close · as of Oct 2, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 6. EXHIBITS
| Exhibit · Incorporated by Reference | |||||
|---|---|---|---|---|---|
| Number | Description | Form | File No. | Exhibit | Filing Date |
| 3.1.1 | Amended and Restated Certificate of Incorporation of the Registrant. | 8-K | 001-38677 | 3.1 | 10/1/2018 |
| 3.1.2 | Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant. (effective 11/16/20) | 8-K | 001-38677 | 3.1 | 11/17/2020 |
| 3.1.3 | Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant. (effective 09/30/22) | 8-K | 001-38677 | 3.1 | 9/20/2022 |
| 3.1.4 | Certificate of Amendment to Amended and Restated Certificate of Incorporation of the Registrant. (filed 08/01/23, effective 08/17/23) | 8-K | 001-38677 | 3.1 | 8/4/2023 |
| 5 | Certificate of Designation of Series X Convertible Preferred Stock. | 8-K | 001-38677 | 3.1 | 1/13/2023 |
| 6 | Certificate of Designation of Series A Preferred Stock. | 8-K | 001-38677 | 3.2 | 1/13/2023 |
| 3.2.1 | Amended and Restated Bylaws of the Registrant. | 8-K | 001-38677 | 3.2 | 10/1/2018 |
| 3.2.2 | Amendment to Amended and Restated Bylaws of the Registrant. | 8-K | 001-38677 | 3.1 | 8/17/2022 |
| 4.1 | Specimen common stock certificate of the Registrant. | S-1 | 333-226191 | 4.1 | 7/16/2018 |
| 4.2 | [omitted.] | ||||
| 4.3 | Form of warrant issued in May 2020. | 8-K | 001-38677 | 4.1 | 5/22/2020 |
| 4.4 | Form of pre-funded warrant issued in May 2020. | 8-K | 001-38677 | 4.2 | 5/22/2020 |
| 4.5 | Form of placement agent warrant issued in May 2020. | 8-K | 001-38677 | 4.3 | 5/22/2020 |
| Exhibit · Incorporated by Reference | |||||
|---|---|---|---|---|---|
| Number | Description | Form | File No. | Exhibit | Filing Date |
| 4.6 | Form of warrant offered in July 2020. | S-1 | 333-239887 | 4.3 | 7/16/2020 |
| 4.7 | Form of pre-funded warrant issued in July 2020. | S-1 | 333-239887 | 4.4 | 7/16/2020 |
| 4.8 | Form of placement agent warrant offered in July 2020. | S-1 | 333-239887 | 4.5 | 7/16/2020 |
| 4.9 | [omitted.] | ||||
| 4.10 | Form of Series B Warrant offered in February 2022. | S-1/A | 333-262195 | 4.9 | 2/3/2022 |
| 4.11 | [omitted.] | S-1/A | 333-262195 | 4.10 | 2/3/2022 |
| 4.12 | Warrant Agency Agreement, dated February 8, 2022, by and between the Registrant and American Stock & Trust Company LLC. | 8-K | 001-38677 | 4.4 | 2/9/2022 |
| 4.12.1 | Amendment No. 1, dated July 22, 2022, to February 8, 2022 Warrant Agency Agreement by and between the Company and American Stock Transfer & Trust Company, LLC. | 10-Q | 001-38677 | 4.7 | 8/15/2022 |
| 4.13 | Form of Series E Warrant offered in January 2023. | 8-K | 001-38677 | 4.1 | 1/13/2023 |
| 4.14 | Form of Series F Warrant issued in March 2023. | 8-K | 001-38677 | 4.2 | 1/13/2023 |
| 4.15 | Form of Series G Warrant issued in March 2023. | 8-K | 001-38677 | 4.3 | 1/13/2023 |
| Exhibit | Incorporated by Reference | ||||
|---|---|---|---|---|---|
| Number | Description | Form | File No. | Exhibit | Filing Date |
| 31.1* | Certification of Principal Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||
| 31.2* | Certification of Principal Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||||
| 32.1** | Certifications of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||
| 32.2** | Certifications of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||
| 101.INS* | Inline XBRL Instance Document |
|---|---|
| 101.SCH* | Inline XBRL Taxonomy Extension Schema Document |
| 101.CAL* | Inline XBRL Taxonomy Extension Calculation Linkbase Document |
| 101.DEF* | Inline XBRL Taxonomy Extension Definition Linkbase Document |
| 101.LAB* | Inline XBRL Taxonomy Extension Label Linkbase Document |
| 101.PRE* | Inline XBRL Taxonomy Extension Presentation Linkbase Document |
| 104* | Cover Page Interactive Data File (embedded within the Inline XBRL document). |
| * | Filed herewith. |
|---|---|
| ** | The information in this exhibit is furnished and deemed not filed with the Securities and Exchange Commission for purposes of section 18 of the Exchange Act of 1934, as amended (Exchange Act), and is not to be incorporated by reference into any filing of Catheter Precision, Inc. under the Securities Act of 1933, as amended (Securities Act), or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.